Viewing StudyNCT03230292



Ignite Creation Date: 2024-05-06 @ 10:21 AM
Last Modification Date: 2024-10-26 @ 12:28 PM
Study NCT ID: NCT03230292
Status: COMPLETED
Last Update Posted: 2022-07-22
First Post: 2017-07-24

Brief Title: A Study to Evaluate the Long-term Safety Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis
Sponsor:
Organization: UCB Pharma